How GoodRx Built a $2.8B Business by Discounting Drugs
Doug Hirsch had no initial plans to enter the health-care industry. A seasoned tech entrepreneur with stints at Yahoo and Facebook, he was brainstorming ideas in 2010 when a glaring…
Doug Hirsch had no initial plans to enter the health-care industry. A seasoned tech entrepreneur with stints at Yahoo and Facebook, he was brainstorming ideas in 2010 when a glaring…
Allied healthcare professionals, such as radiology technologists and therapists, are substantial revenue generators for healthcare facilities, according to a recent report from AMN Healthcare, a leading provider of healthcare workforce…
Teladoc Health, Inc. (NYSE: TDOC), a global leader in comprehensive virtual care, has appointed Charles “Chuck” Divita, III, as its Chief Executive Officer, effective immediately. Alongside this role, Mr. Divita…
Haemonetics Corporation (NYSE: HAE), a global leader in medical technology aimed at enhancing patient outcomes, has initiated a limited market rollout of its latest innovation, the VASCADE MVP® XL mid-bore…
Medibank announced today that it will increase its give back commitment from $215 million to $305 million as part of its COVID-19 support package and give back program for Medibank…
BioHorizons today announced the release of Tapered Pro Conical, its inaugural dental implant incorporating a deep conical connection. This new implant underscores BioHorizons’ commitment to developing innovative products that enhance…
Maddie Davidson, the first female trampolinist to represent New Zealand at the Tokyo 2020 Olympic Games (held in 2021), recently captivated residents of Kevin Hickman Village with insights into her…
Premier, Inc. (NASDAQ: PINC), a leading technology-enabled healthcare improvement company, has been named one of the Best Companies to Work For in 2024-2025 by U.S. News & World Report for…
Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, has announced that its Board of Directors has appointed Charles “Chuck” Divita, III, as Chief Executive Officer, effective…
Celltrion Reveals Positive Phase III Data for CT-P47 Biosimilar at EULAR 2024 Celltrion presented encouraging Phase III data for CT-P47, a biosimilar candidate referencing RoActemra® in patients with moderate to…
A recent study of Phoenix’s bioscience ecosystem has pinpointed three areas poised for significant growth and global impact, centered around the Phoenix Bioscience Core and surrounding regional hubs of research…
Bristol Myers Squibb (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Augtyro™ (repotrectinib) for treating adult and pediatric patients aged 12 and…